chr8-132480483-T-TCGC
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP5BS2
The NM_004519.4(KCNQ3):c.47_49dupGCG(p.Gly16dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,211,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000047 ( 0 hom. )
Consequence
KCNQ3
NM_004519.4 conservative_inframe_insertion
NM_004519.4 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.552
Genes affected
KCNQ3 (HGNC:6297): (potassium voltage-gated channel subfamily Q member 3) This gene encodes a protein that functions in the regulation of neuronal excitability. The encoded protein forms an M-channel by associating with the products of the related KCNQ2 or KCNQ5 genes, which both encode integral membrane proteins. M-channel currents are inhibited by M1 muscarinic acetylcholine receptors and are activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP5
Variant 8-132480483-T-TCGC is Pathogenic according to our data. Variant chr8-132480483-T-TCGC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 538549.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Likely_pathogenic=1}.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ3 | NM_004519.4 | c.47_49dupGCG | p.Gly16dup | conservative_inframe_insertion | 1/15 | ENST00000388996.10 | NP_004510.1 | |
KCNQ3 | XM_047421769.1 | c.47_49dupGCG | p.Gly16dup | conservative_inframe_insertion | 1/15 | XP_047277725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ3 | ENST00000388996.10 | c.47_49dupGCG | p.Gly16dup | conservative_inframe_insertion | 1/15 | 1 | NM_004519.4 | ENSP00000373648.3 | ||
KCNQ3 | ENST00000519445.5 | c.47_49dupGCG | p.Gly16dup | conservative_inframe_insertion | 1/15 | 5 | ENSP00000428790.1 |
Frequencies
GnomAD3 genomes AF: 0.0000473 AC: 7AN: 147890Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
7
AN:
147890
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000470 AC: 5AN: 1063240Hom.: 0 Cov.: 31 AF XY: 0.00000590 AC XY: 3AN XY: 508208
GnomAD4 exome
AF:
AC:
5
AN:
1063240
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
508208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000473 AC: 7AN: 147890Hom.: 0 Cov.: 33 AF XY: 0.0000277 AC XY: 2AN XY: 72080
GnomAD4 genome
AF:
AC:
7
AN:
147890
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
72080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Benign neonatal seizures Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 07, 2023 | ClinVar contains an entry for this variant (Variation ID: 538549). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has been observed in individuals with KCNQ3-related conditions (Invitae). This variant is not present in population databases (gnomAD no frequency). This variant, c.47_49dup, results in the insertion of 1 amino acid(s) of the KCNQ3 protein (p.Gly16dup), but otherwise preserves the integrity of the reading frame. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 08, 2021 | The c.47_49dupGCG (p.G16dup) alteration is located in exon 1 (coding exon 1) of the KCNQ3 gene. The alteration consists of an in-frame duplication of 3 nucleotides from position 47 to 49, resulting in the duplication of 1 residue. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 26, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In-frame insertion of one amino acid in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at